Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115417793A reveals a streamlined route for (E)-2-methyl-α-methoxyiminophenylacetic acid methyl ester, offering significant cost and purity advantages.
Patent CN101208292A details a safe, high-yield process for converting hydroxamic acids to amines using alkylphosphonic anhydrides, offering significant cost reduction in amine manufacturing.
High-purity pharmaceutical intermediate via selective iodination. Cost-effective zeolite process ensures supply chain stability and reduced purification loads for global buyers.
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.
Patent CN1373116A reveals a novel resolution method for agrochemical intermediates, offering significant cost reduction and supply chain reliability for pyrethroid manufacturers globally.
Patent CN116376872A reveals high-efficiency esterase mutants for (S)-3-cyclohexene-1-carboxylic acid, offering cost reduction and scalable biocatalysis for anticoagulant manufacturing.
Novel peptide coupling method ensures high purity Nebivolol intermediate with reduced racemization risks for scalable pharmaceutical manufacturing.
Patent CN1158244C details a high-purity L-carnitine process from S-chlorosuccinic acid. Discover cost-effective chiral synthesis strategies for pharmaceutical intermediates.
Patent CN102548956B details a novel Stevens rearrangement process for high-purity DTPA derivatives, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN111170855A reveals a safer, scalable route for Bempedoic Acid intermediates, offering significant cost reduction in pharmaceutical manufacturing and improved purity profiles.
Patent CN102164930A reveals a novel two-step catalytic route for high-purity dialkylphosphinic acids. Discover cost-effective, halogen-free flame retardant solutions for polymers.
Advanced resolution process for IRS drug intermediates via diastereomeric salt crystallization. Enhances purity and reduces manufacturing costs for pharmaceutical supply chains.
Patent CN106573005B reveals an efficient furfural-based route for 4-alkoxy-3-hydroxypicolinic acid, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN105392891B enables high-yield production of optically active D/L amino acids with thiol groups. Enhances supply chain reliability and reduces manufacturing costs for peptide synthesis.
Patent CN103387494A reveals a novel amine-mediated demethylation route for 2-hydroxy-4,5-dimethoxybenzoic acid, offering significant cost reduction and safer manufacturing for Acotiamide intermediates.
Discover a novel high-yield synthesis for Obeticholic Acid intermediates via Weinreb amide protection. Enhance purity to 99.9% and reduce manufacturing costs significantly.
Novel lipase mutant enables efficient synthesis of chiral intermediates. Reduces solvent use and enhances supply chain reliability for global pharmaceutical manufacturing.
Patent CN106905177A details high-yield synthesis for AHU-377 intermediate. Offers cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Patent CN114773181B reveals high purity palladium catalyst precursor synthesis. Achieves 99.95% purity with reduced impurities for reliable supply chain and cost efficiency.
Novel patent CN113880704B offers high-purity 18O-labeled aldehydes. Reduces heavy oxygen water loss and simplifies scale-up for pharmaceutical intermediates manufacturing globally.